Catalytic inhibition of MLL through OICR-9429 administration to EC attenuated hyperglycemia dependent induction of mesenchymal genes α-SMA and Slug (Figure 6A) in EC without altering the level of endothelial surface markers CD31 and CD144 (data not shown). The gene discussed is KMT2A; the disease is Hyperglycemia.